Monday Jul 28
The Upsher-Smith Laboratories Galaxy??? Portfolio Of Antiepileptic Drugs Now Available
The current Upsher-Smith Galaxy Portfolio includes seven frequently prescribed AEDs which represent more than one out of every three prescriptions written for seizure disorders.1 The launch of the Upsher-Smith Galaxy demonstrates the company's commitment to simplifying access to effective treatments and reducing healthcare costs.
Is Off-Label Drug Promotion Protected Free Speech?
It is a very common practice. Drug sales reps visit a client, usually a hospital, a clinic or a doctor, with the sole purpose of selling a drug or medical device.
Upsher-Smith Laboratories Announces Immediate Availability Of A...
Qudexy XR and Topiramate Extended-Release Capsules are indicated as initial monotherapy in patients 10 years of age and older with partial-onset seizures or primary generalized tonic-clonic seizures.
The Washington Post
FDA weighs free speech, patient safety as it reviews rules
Should a pharmaceutical sales rep be allowed to tell a doctor that Topamax, a drug approved to treat seizures and prevent migraine headaches, might also help combat alcohol dependence ? Or suggest the epilepsy drug Neurontin could also help treat bipolar disorders or insomnia? Or offer data showing that any number of other drugs could have uses ... (more)
Applied Clinical Trials
Upsher-Smith Launches Qudexy? XR (Topiramate) Extended-Release...
Qudexy XR is a once-daily, broad-spectrum antiepileptic drug specifically engineered to deliver a smooth pharmacokinetic profile.